{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:38:20Z","timestamp":1778539100323,"version":"3.51.4"},"reference-count":101,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233820","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T13:23:18Z","timestamp":1597670598000},"page":"e0233820","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington\u2019s disease"],"prefix":"10.1371","volume":"15","author":[{"given":"Alexander J.","family":"Lowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Sj\u00f6din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-7938","authenticated-orcid":true,"given":"Filipe B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-9891","authenticated-orcid":true,"given":"Rosanna","family":"Tortelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-7887","authenticated-orcid":true,"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"issue":"4","key":"pone.0233820.ref001","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"pone.0233820.ref002","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"issue":"5","key":"pone.0233820.ref003","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington\u2019s disease and related disorders","volume":"35","author":"CA Ross","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"pone.0233820.ref004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-neuro-071013-014149","article-title":"Autophagy and Its Normal and Pathogenic States in the Brain","volume":"37","author":"A Yamamoto","year":"2014","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"pone.0233820.ref005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/cr.2013.168","article-title":"The machinery of macroautophagy","volume":"24","author":"Y Feng","year":"2014","journal-title":"Cell Res"},{"issue":"10","key":"pone.0233820.ref006","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.228114","article-title":"Autophagy and endocytosis\u2013interconnections and interdependencies","volume":"133","author":"\u00c5B Birgisdottir","year":"2020","journal-title":"J Cell Sci"},{"issue":"10","key":"pone.0233820.ref007","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1242\/bio.018648","article-title":"LAMP-2 is required for incorporating syntaxin-17 into autophagosomes and for their fusion with lysosomes","volume":"5","author":"V Hubert","year":"2016","journal-title":"Biol Open"},{"issue":"3","key":"pone.0233820.ref008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1083\/jcb.201603105","article-title":"Syntaxin-17 delivers PINK1\/parkin-dependent mitochondrial vesicles to the endolysosomal system","volume":"214","author":"GL McLelland","year":"2016","journal-title":"J Cell Biol"},{"key":"pone.0233820.ref009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2018.08.010","article-title":"A role for autophagy in Huntington\u2019s disease","volume":"122","author":"KR Croce","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"3","key":"pone.0233820.ref010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41556-018-0037-z","article-title":"Cargo recognition and degradation by selective autophagy","volume":"20","author":"D Gatica","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"7","key":"pone.0233820.ref011","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"E Wong","year":"2010","journal-title":"Nat Neurosci"},{"issue":"4","key":"pone.0233820.ref012","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(07)70076-5","article-title":"Autophagy and neurodegeneration: when the cleaning crew goes on strike","volume":"6","author":"M Martinez-Vicente","year":"2007","journal-title":"Lancet Neurol"},{"issue":"6","key":"pone.0233820.ref013","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/abbs\/gmp031","article-title":"Review: The lysosome and neurodegenerative diseases","volume":"41","author":"L Zhang","year":"2009","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"2","key":"pone.0233820.ref014","first-page":"777","article-title":"Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"M Martinez-Vicente","year":"2008","journal-title":"J Clin Invest"},{"issue":"21","key":"pone.0233820.ref015","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","article-title":"Tau fragmentation, aggregation and clearance: The dual role of lysosomal processing","volume":"18","author":"Y Wang","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"50","key":"pone.0233820.ref016","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1523\/JNEUROSCI.3219-11.2011","article-title":"Constitutive upregulation of chaperone-mediated autophagy in Huntington\u2019s disease","volume":"31","author":"H Koga","year":"2011","journal-title":"J Neurosci"},{"issue":"5","key":"pone.0233820.ref017","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease","volume":"13","author":"M Martinez-Vicente","year":"2010","journal-title":"Nat Neurosci"},{"issue":"17","key":"pone.0233820.ref018","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4161\/cc.9.17.12718","article-title":"Does Huntingtin play a role in selective macroautophagy?","volume":"9","author":"JS Steffan","year":"2010","journal-title":"Cell Cycle"},{"issue":"47","key":"pone.0233820.ref019","doi-asserted-by":"crossref","first-page":"16889","DOI":"10.1073\/pnas.1420103111","article-title":"Potential function for the Huntingtin protein as a scaffold for selective autophagy","volume":"111","author":"J Ochaba","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pone.0233820.ref020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"YN Rui","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"8","key":"pone.0233820.ref021","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.jmb.2019.11.012","article-title":"Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington\u2019s Disease","volume":"432","author":"E Valionyte","year":"2020","journal-title":"J Mol Biol"},{"issue":"19","key":"pone.0233820.ref022","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/hmg\/ddq285","article-title":"Early autophagic response in a novel knock-in model of Huntington disease","volume":"19","author":"MY Heng","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"6","key":"pone.0233820.ref023","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1242\/jcs.179978","article-title":"Distinguishing aggregate formation and aggregate clearance using cell-based assays","volume":"129","author":"E Eenjes","year":"2016","journal-title":"J Cell Sci"},{"issue":"5\u20136","key":"pone.0233820.ref024","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","article-title":"Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy","volume":"27","author":"EL Eskelinen","year":"2006","journal-title":"Mol Aspects Med"},{"issue":"2","key":"pone.0233820.ref025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.emboj.7601511","article-title":"LAMP proteins are required for fusion of lysosomes with phagosomes","volume":"26","author":"KK Huynh","year":"2007","journal-title":"EMBO J"},{"issue":"1","key":"pone.0233820.ref026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2012.07.044","article-title":"Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson\u2019s disease","volume":"526","author":"S Pang","year":"2012","journal-title":"Neurosci Lett"},{"issue":"12","key":"pone.0233820.ref027","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"L Alvarez-Erviti","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"pone.0233820.ref028","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12017-013-8269-3","article-title":"Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer\u2019s disease","volume":"16","author":"A Armstrong","year":"2014","journal-title":"NeuroMolecular Med"},{"issue":"1","key":"pone.0233820.ref029","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35376-6","article-title":"Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson\u2019s Disease","volume":"8","author":"J Youn","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0233820.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-016-9104-2","article-title":"Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry","volume":"13","author":"S Sj\u00f6din","year":"2016","journal-title":"Clin Proteomics"},{"issue":"11","key":"pone.0233820.ref031","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"129","author":"K Buerger","year":"2006","journal-title":"Brain"},{"issue":"1","key":"pone.0233820.ref032","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"RC Block","year":"2010","journal-title":"J Clin Lipidol"},{"issue":"7","key":"pone.0233820.ref033","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","article-title":"The many faces of autophagy dysfunction in Huntington\u2019s disease: From mechanism to therapy","volume":"19","author":"CJ Cortes","year":"2014","journal-title":"Drug Discov Today"},{"issue":"9","key":"pone.0233820.ref034","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","article-title":"Lysosomal degradation of membrane lipids","volume":"584","author":"T Kolter","year":"2010","journal-title":"FEBS Lett"},{"issue":"6","key":"pone.0233820.ref035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00125817-200011000-00003","article-title":"The GM2 gangliosidoses databases: Allelic variation at the HEXA, HEXB, and GM2A gene loci","volume":"2","author":"P Cordeiro","year":"2000","journal-title":"Genet Med"},{"issue":"1","key":"pone.0233820.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0059-y","article-title":"Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay","volume":"10","author":"WE Heywood","year":"2015","journal-title":"Mol Neurodegener"},{"issue":"1","key":"pone.0233820.ref037","article-title":"Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"11","author":"S Sj\u00f6din","year":"2019","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"5","key":"pone.0233820.ref038","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1021\/pr301200e","article-title":"The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: Evidence of presymptomatic kidney disease in pediatric fabry and type-I diabetic patients","volume":"12","author":"V Manwaring","year":"2013","journal-title":"J Proteome Res"},{"issue":"3","key":"pone.0233820.ref039","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","article-title":"Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease","volume":"27","author":"PA Desplats","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"11","key":"pone.0233820.ref040","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1","volume":"30","author":"V Maglione","year":"2010","journal-title":"J Neurosci"},{"issue":"9","key":"pone.0233820.ref041","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1073\/pnas.1114502109","article-title":"Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice","volume":"109","author":"A Di Pardo","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pone.0233820.ref042","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","article-title":"Brain gangliosides in axon-myelin stability and axon regeneration","volume":"584","author":"RL Schnaar","year":"2010","journal-title":"FEBS Lett"},{"issue":"4","key":"pone.0233820.ref043","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.25309","article-title":"In vivo characterization of white matter pathology in premanifest huntington\u2019s disease","volume":"84","author":"J Zhang","year":"2018","journal-title":"Ann Neurol"},{"issue":"9","key":"pone.0233820.ref044","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","article-title":"Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: Selective white matter pathology and its relationship to clinical measures","volume":"21","author":"HD Rosas","year":"2006","journal-title":"Mov Disord"},{"issue":"1","key":"pone.0233820.ref045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/mdc3.12866","article-title":"Characterizing White Matter in Huntington\u2019s Disease","volume":"7","author":"S Gregory","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"pone.0233820.ref046","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","article-title":"Lysosomal cathepsins and their regulation in aging and neurodegeneration","volume":"32","author":"V Stoka","year":"2016","journal-title":"Ageing Res Rev"},{"issue":"21","key":"pone.0233820.ref047","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1074\/jbc.M112.352781","article-title":"Cathepsins L and Z are critical in degrading polyglutamine-containing proteins within lysosomes","volume":"287","author":"N Bhutani","year":"2012","journal-title":"J Biol Chem"},{"key":"pone.0233820.ref048","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-510X(95)00035-Z","article-title":"Comparison of Cathepsin Protease Activities in Brain-Tissue From Normal Cases and Cases With Alzheimers-Disease, Lewy Body Dementia, Parkinsons-Disease and Huntingtons-Disease","volume":"131","author":"D MANTLE","year":"1995","journal-title":"J Neurol Sci"},{"issue":"2","key":"pone.0233820.ref049","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2005.11.012","article-title":"Lysosomal proteases are involved in generation of N-terminal huntingtin fragments","volume":"22","author":"YJ Kim","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"1","key":"pone.0233820.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-37","article-title":"Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons","volume":"6","author":"Q Liang","year":"2011","journal-title":"Mol Neurodegener"},{"issue":"3\u20134","key":"pone.0233820.ref051","first-page":"79","article-title":"Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics","volume":"21","author":"H Reiber","year":"2003","journal-title":"Restor Neurol Neurosci"},{"issue":"1","key":"pone.0233820.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal Fluid Biomarkers for Huntington\u2019s Disease","volume":"5","author":"LM Byrne","year":"2016","journal-title":"J Huntingtons Dis"},{"issue":"11","key":"pone.0233820.ref053","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","article-title":"Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics","volume":"11","author":"AC Peterson","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"pone.0233820.ref054","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jprot.2012.11.005","article-title":"Selectivity of LC-MS\/MS analysis: Implication for proteomics experiments","volume":"81","author":"S Gallien","year":"2013","journal-title":"J Proteomics"},{"issue":"1","key":"pone.0233820.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21788-x","article-title":"Cerebrospinal fluid neurogranin and TREM2 in Huntington\u2019s disease","volume":"8","author":"LM Byrne","year":"2018","journal-title":"Sci Rep"},{"issue":"458","key":"pone.0233820.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aat7108","article-title":"Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease","volume":"10","author":"LM Byrne","year":"2018","journal-title":"Sci Transl Med"},{"key":"pone.0233820.ref057","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s Disease Rating Scale: Reliability and-Consistency","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Mov Disord"},{"issue":"24","key":"pone.0233820.ref058","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","article-title":"Motor, cognitive, and functional declines contribute to a single progressive factor in early HD","volume":"89","author":"SA Schobel","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"pone.0233820.ref059","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in huntington\u2019s disease","volume":"41","author":"JB Penney","year":"1997","journal-title":"Ann Neurol"},{"issue":"7","key":"pone.0233820.ref060","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: Analysis of 36-month observational data","volume":"12","author":"SJ Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"pone.0233820.ref061","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700131","article-title":"A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer\u2019s Disease","volume":"12","author":"G Brinkmalm","year":"2018","journal-title":"Proteomics\u2014Clin Appl"},{"issue":"9","key":"pone.0233820.ref062","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/pr200156b","article-title":"Improving SRM assay development: A global comparison between triple quadrupole, Ion trap, and higher energy CID peptide fragmentation spectra","volume":"10","author":"EL De Graaf","year":"2011","journal-title":"J Proteome Res"},{"issue":"7","key":"pone.0233820.ref063","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: An open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"B MacLean","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"pone.0233820.ref064","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/096228029200100105","article-title":"Principal component analysis and exploratory factor analysis","volume":"1","author":"IT Joliffe","year":"1992","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"pone.0233820.ref065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1015210025234","article-title":"Exploratory factor analysis in behavior genetics research: Factor recovery with small sample sizes","volume":"32","author":"KJ Preacher","year":"2002","journal-title":"Behav Genet"},{"issue":"6","key":"pone.0233820.ref066","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-Export Ferroxidase Activity of \u03b2-Amyloid Precursor Protein is Inhibited by Zinc in Alzheimer\u2019s Disease","volume":"142","author":"JA Duce","year":"2010","journal-title":"Cell"},{"issue":"7","key":"pone.0233820.ref067","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","article-title":"Alterations in brain transition metals in Huntington disease: An evolving and intricate story","volume":"69","author":"HD Rosas","year":"2012","journal-title":"Arch Neurol"},{"issue":"10","key":"pone.0233820.ref068","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"RJ Ward","year":"2014","journal-title":"Lancet Neurol"},{"issue":"3","key":"pone.0233820.ref069","first-page":"1","article-title":"Mechanisms of copper ion mediated Huntington\u2019s disease progression","volume":"2","author":"JH Fox","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"pone.0233820.ref070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JHD-170242","article-title":"Amyloid precursor protein haploinsufficiency preferentially mediates brain iron accumulation in mice transgenic for the Huntington\u2019s disease mutation","volume":"6","author":"K Berggren","year":"2017","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"pone.0233820.ref071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006288","article-title":"Physiological functions of APP family proteins","volume":"2","author":"UC M\u00fcller","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"pone.0233820.ref072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"C Haass","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"pone.0233820.ref073","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"pone.0233820.ref074","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.mp.4001473","article-title":"Value of CSF \u03b2-amyloid 1\u201342 and tau as predictors of Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"9","author":"H Hampel","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"2","key":"pone.0233820.ref075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/01.wnl.0000171397.32851.bc","article-title":"Familial Alzheimer disease: Decreases in CSF A\u03b242 levels precede cognitive decline","volume":"65","author":"M Moonis","year":"2005","journal-title":"Neurology"},{"issue":"16","key":"pone.0233820.ref076","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased \u03b2-Amyloid1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients with Alzheimer Disease","volume":"289","author":"T Sunderland","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"11","key":"pone.0233820.ref077","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","article-title":"Beta Amyloid in Alzheimer\u2019s Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid","volume":"65","author":"T Grimmer","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"1","key":"pone.0233820.ref078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1096-9896(200105)194:1<1::AID-PATH871>3.0.CO;2-M","article-title":"How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer\u2019s diseases?","volume":"194","author":"RO Weller","year":"2001","journal-title":"J Pathol"},{"issue":"20","key":"pone.0233820.ref079","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","article-title":"CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings","volume":"78","author":"TT Sepp\u00e4l\u00e4","year":"2012","journal-title":"Neurology"},{"issue":"14","key":"pone.0233820.ref080","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","volume":"85","author":"S Palmqvist","year":"2015","journal-title":"Neurology"},{"issue":"16","key":"pone.0233820.ref081","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1523\/JNEUROSCI.17-16-06142.1997","article-title":"Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer\u2019s disease: Neuropathologic evidence for a mechanism of increased \u03b2-amyloidogenesis","volume":"17","author":"AM Cataldo","year":"1997","journal-title":"J Neurosci"},{"issue":"3","key":"pone.0233820.ref082","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/jpet.108.147082","article-title":"Cathepsins B and L differentially regulate amyloid precursor protein processing","volume":"328","author":"DM Klein","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"pone.0233820.ref083","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","article-title":"Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer\u2019s Disease","volume":"60","author":"B Sun","year":"2008","journal-title":"Neuron"},{"issue":"6","key":"pone.0233820.ref084","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer\u2019s Disease","volume":"51","author":"S Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"issue":"4","key":"pone.0233820.ref085","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-2010-101023","article-title":"Higher cathepsin B levels in plasma in Alzheimer\u2019s disease compared to healthy controls","volume":"22","author":"J Sundel\u00f6f","year":"2010","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"5","key":"pone.0233820.ref086","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/jm101443u","article-title":"Crystal structure of \u03b2-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone","volume":"54","author":"KS Bateman","year":"2011","journal-title":"J Med Chem"},{"issue":"2\u20133","key":"pone.0233820.ref087","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4439(99)00074-5","article-title":"Biochemical consequences of mutations causing the GM2 gangliosidoses","volume":"1455","author":"DJ Mahuran","year":"1999","journal-title":"Biochim Biophys Acta\u2014Mol Basis Dis"},{"issue":"2","key":"pone.0233820.ref088","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg","volume":"40","author":"A Ciechanover","year":"2003","journal-title":"Neuron"},{"issue":"4","key":"pone.0233820.ref089","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2007.05.007","article-title":"Proteasomes: Machines for All Reasons","volume":"129","author":"GN DeMartino","year":"2007","journal-title":"Cell"},{"issue":"10","key":"pone.0233820.ref090","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/ene.12750","article-title":"Ubiquitin: A potential cerebrospinal fluid progression marker in Huntington\u2019s disease","volume":"22","author":"T Vinther-Jensen","year":"2015","journal-title":"Eur J Neurol"},{"issue":"6","key":"pone.0233820.ref091","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington\u2019s disease mice","volume":"180","author":"J Wang","year":"2008","journal-title":"J Cell Biol"},{"issue":"8","key":"pone.0233820.ref092","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jnr.21287","article-title":"Ubiquitin-proteasome system alterations in a striatal cell model of Huntington\u2019s disease","volume":"85","author":"JM Hunter","year":"2007","journal-title":"J Neurosci Res"},{"issue":"7154","key":"pone.0233820.ref093","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington\u2019s disease","volume":"448","author":"EJ Bennett","year":"2007","journal-title":"Nature"},{"issue":"SEP","key":"pone.0233820.ref094","article-title":"Ubiquitin-proteasome system involvement in huntington\u2019s disease","volume":"7","author":"Z Ortega","year":"2014","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"pone.0233820.ref095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"JV Sarma","year":"2011","journal-title":"Cell Tissue Res"},{"issue":"5","key":"pone.0233820.ref096","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molimm.2006.03.007","article-title":"Role of complement in neurodegeneration and neuroinflammation","volume":"44","author":"DM Bonifati","year":"2007","journal-title":"Mol Immunol"},{"issue":"1\u20132","key":"pone.0233820.ref097","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"P Gasque","year":"2000","journal-title":"Immunopharmacology"},{"issue":"7058","key":"pone.0233820.ref098","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","article-title":"Structures of complement component C3 provide insights into the function and evolution of immunity","volume":"437","author":"BJC Janssen","year":"2005","journal-title":"Nature"},{"issue":"7","key":"pone.0233820.ref099","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"A Dalrymple","year":"2007","journal-title":"J Proteome Res"},{"issue":"9","key":"pone.0233820.ref100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0163479","article-title":"Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in huntington\u2019s disease","volume":"11","author":"FB Rodrigues","year":"2016","journal-title":"PLoS One"},{"key":"pone.0233820.ref101","unstructured":"Wild EJ, Borowsky B Hdc investigators. HDClarity: A new multi-site cerebrospinal fluid collection initiative to facilitate therapeutic development for Huntington\u2019s disease. In: 11th Annual CHDI HD Therapeutics Conference. Palm Spring, CA; 2016."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T13:27:25Z","timestamp":1597670845000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233820"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":101,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233820","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.14.095828","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]}}}